Sign inCreate account

Report workspace tools

NCT06772272ACTIVE_NOT_RECRUITINGanonymous

Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery: a Parallel-group, Open-label, Randomised Controlled Trial.

Sponsor

Source record

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase

Source record

PHASE3

Modality

AI-normalized

small molecule

Target

AI-normalized

Perioperative Anemia

Indication / condition

AI-normalized

Perioperative Anemia

Intervention

Source record

Roxadustat

Source & freshness

Source record

NCT ID

NCT06772272

Original source

ClinicalTrials.gov

Source last updated

Jan 13, 2025

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT06772272

Title

Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery: a Parallel-group, Open-label, Randomised Controlled Trial.

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Status

ACTIVE_NOT_RECRUITING

Phase

PHASE3

Condition raw

Perioperative Anemia

Condition normalized

Perioperative Anemia

Modality raw

Perioperative Anemia

Modality normalized

small molecule

Target raw

Perioperative Anemia

Target normalized

Perioperative Anemia

Interventions

Roxadustat

Public preview

Source record

This clinical trial investigates the efficacy and safety of Roxadustat in reducing perioperative blood transfusions in patients with anemia undergoing elective lumbar interbody fusion surgery. The study aims to provide insights into the potential market for Roxadustat in surgical settings, particularly for patients with anemia, which is a significant concern in surgical outcomes.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery: a Parallel-group, Open-label, Randomised Controlled Trial.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT06772272

Status

ACTIVE_NOT_RECRUITING

Phase

PHASE3

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Executive brief

Investment-Ready Snapshot

This clinical trial investigates the efficacy and safety of Roxadustat in reducing perioperative blood transfusions in patients with anemia undergoing elective lumbar interbody fusion surgery. The study aims to provide insights into the potential market for Roxadustat in surgical settings, particularly for patients with anemia, which is a significant concern in surgical outcomes.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedJan 13, 2025
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT06772272

Indication

Perioperative Anemia

Modality

small molecule

Target

Perioperative Anemia

Intervention

Roxadustat

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.